Carregant...
Attitudes of Individuals with Gaucher Disease toward Substrate Reduction Therapies
Type 1 Gaucher disease (GD) is the most common lysosomal storage disorder. Previously, treatment for GD was limited to intravenous enzyme replacement therapies (ERTs). More recently, oral substrate reduction therapies (SRTs) were approved for treatment of GD. Although both therapies alleviate diseas...
Guardat en:
| Publicat a: | J Genet Couns |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5794801/ https://ncbi.nlm.nih.gov/pubmed/28803392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10897-017-0137-0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|